Phase I trial of the safety and immunogenicity of a tri-antigen vaccine targeting HER2, IGFBP-2, and IGF-IR in patients with non-metastatic breast cancerSasha E. Stanton,Kari B. Wisinski, William R. Gwin,Andrew Coveler,John B. Liao,Mark Burkard,Howard Bailey,KyungMann Kim,Thomas Havinghurst, Katina DeShong,Jennifer S. Childs,Eileen Dimond, Margaret Wojtowicz,Brandy M. Heckman-Stoddard,Denise Cecil,Mary DisisCANCER RESEARCH（2023）引用 0|浏览11暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
